Bristol-Myers SquibbvsJohnson & Johnson

BMY and JNJ stock compared: price, dividend, valuation and results, from SEC filings.

BMY

Bristol-Myers Squibb Company

$58.34

Value $119B

-2.05%
BMY's page

Bristol-Myers Squibb (BMY) has a market value of $119B and Johnson & Johnson (JNJ) $644B. Over the last year, with dividends, BMY moved +29.4% and JNJ +36.6%. The P/E is 12.9 for BMY and 40.0 for JNJ. Dividend yield: BMY 4.32%, JNJ 1.98%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    BMY$119B

    JNJ$644B

    JNJ is 5.4 times BMY

  • Revenue, 12 months

    BMY$50.0B

    JNJ$99.3B

    JNJ is 2.0 times BMY

  • Net income, 12 months

    BMY$9.2B

    JNJ$16.1B

    JNJ is 1.7 times BMY

  • Operating margin

    BMY–

    JNJ–

  • ROIC

    BMY14.1%

    JNJ12.4%

    1.7 points apart

  • P/E

    BMY12.9

    JNJ40.0

    JNJ is 3.1 times BMY

  • Dividend yield

    BMY4.3%

    JNJ2.0%

    2.3 points apart

  • 5-year return

    BMY+21.5%

    JNJ+89.1%

    67.6 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

BMY+21.5%

JNJ+89.1%

10015020020222023202420252026
Returns by period
PeriodBMYWith dividendsJNJWith dividends
1 year since November 18, 2025+29.4%Price +24.0%+36.6%Price +33.6%
3 years since November 17, 2023+32.1%+9.7% a yearPrice +14.8%+94.2%+24.8% a yearPrice +78.3%
5 years since November 18, 2021+21.5%+4.0% a yearPrice -1.2%+89.1%+13.6% a yearPrice +64.5%
10 years since November 21, 2016+46.9%+3.9% a yearPrice +2.8%+202.7%+11.7% a yearPrice +132.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

BMYBristol-Myers SquibbJNJJohnson & Johnson

Valuation

BMYJNJ
Valuation
Price$58.34$267.14
Market value$119B$644B
Enterprise value (EV)$149B$671B
P/E12.940.0
P/E, 5-year median17.821.9
P/B5.17.9
EV/EBIT13.237.8
Free cash flow yield7.8%3.2%

Results and growth

BMYJNJ
Results and growth
Revenue, 12 months$50.0B$99.3B
Net income, 12 months$9.2B$16.1B
Free cash flow, 12 months$9.3B$20.6B
Earnings per share, 12 months$4.51$6.59
Revenue growth, year on year-0.2%6.1%
Revenue growth a year, past+2.5%over 5 years+2.7%over 5 years
EPS growth a year, past–+14.9%over 5 years

Margins and returns on capital

BMYJNJ
Margins and returns on capital
Gross margin69.2%67.6%
Operating margin––
Net margin18.5%16.2%
ROIC14.1%12.4%
ROE45.0%19.7%

Balance sheet

BMYJNJ
Balance sheet
Cash$12.6B$17.2B
Total debt$44.8B$44.7B
Net debt / EBITDA2.01.1
Interest cover6.9×18.0×

Dividends and buybacks

BMYJNJ
Dividends and buybacks
Dividend yield4.3%2.0%
Dividend per share, 12 months$2.52$5.28
Dividend growth a year, past+6.2%over 5 years+5.3%over 5 years
Buyback yield–0.9%
Shareholder yield4.3%2.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: BMY or JNJ

Didn't find what you were looking for?

Ask us
Which is bigger, Bristol-Myers Squibb or Johnson & Johnson?

By market value, Johnson & Johnson ($644B) is about 5.4 times Bristol-Myers Squibb ($119B), at today's prices.

How did BMY and JNJ stock do over the last 10 years?

Since November 21, 2016, BMY's price moved +2.8% and JNJ's +132.3%. With dividends: BMY +46.9% (+3.9% a year), JNJ +202.7% (+11.7% a year). Past returns do not predict future ones.

Which pays the higher dividend, BMY or JNJ?

The dividend yield at today's price is 4.32% for Bristol-Myers Squibb and 1.98% for Johnson & Johnson. Over the last twelve months they paid $2.52 and $5.28 per share.

What is the P/E of BMY and JNJ?

At today's price, the P/E is 12.9 for BMY and 40.0 for JNJ. The median of the last five years was 17.8 and 21.9, which shows where each stands against its own past.

Which has the higher profit margins, Bristol-Myers Squibb or Johnson & Johnson?

Over the last twelve months, the net margin was 18.5% for Bristol-Myers Squibb and 16.2% for Johnson & Johnson, and the operating margin – and –. Revenue was $50.0B and $99.3B.

Which is the better investment, Bristol-Myers Squibb or Johnson & Johnson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.